Works matching AU Lee, Jong-Seok


Results: 252
    1

    Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study.

    Published in:
    2021
    By:
    • Park, Keunchil;
    • Jӓnne, Pasi A.;
    • Kim, Dong‐Wan;
    • Han, Ji‐Youn;
    • Wu, Ming‐Fang;
    • Lee, Jong‐Seok;
    • Kang, Jin‐Hyoung;
    • Lee, Dae Ho;
    • Cho, Byoung Chul;
    • Yu, Chong‐Jen;
    • Pang, Yong Kek;
    • Felip, Enriqueta;
    • Kim, Hyunjin;
    • Baek, Eunhye;
    • Noh, Young Su;
    • Kim, Dong-Wan;
    • Han, Ji-Youn;
    • Wu, Ming-Fang;
    • Lee, Jong-Seok;
    • Kang, Jin-Hyoung
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 11, p. 2995, doi. 10.1007/s00432-021-03872-4
    By:
    • Kim, Sang-A;
    • Park, Hyejoo;
    • Kim, Kui-Jin;
    • Kim, Ji-Won;
    • Sung, Ji Hea;
    • Nam, Milang;
    • Lee, Ju Hyun;
    • Jung, Eun Hee;
    • Suh, Koung Jin;
    • Lee, Ji Yun;
    • Kim, Se Hyun;
    • Lee, Jeong-Ok;
    • Kim, Jin Won;
    • Kim, Yu Jung;
    • Kim, Jee Hyun;
    • Bang, Soo-Mee;
    • Lee, Jong Seok;
    • Lee, Keun-Wook
    Publication type:
    Article
    26

    Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 8, p. 2459, doi. 10.1007/s00432-021-03527-4
    By:
    • Park, Ji Hyun;
    • You, Gun Lyung;
    • Ahn, Myung-Ju;
    • Kim, Sang-We;
    • Hong, Min Hee;
    • Han, Ji-Youn;
    • Ock, Chan-Young;
    • Lee, Jong-Seok;
    • Oh, In Jae;
    • Lee, Shin Yup;
    • Kim, Cheol Hyeon;
    • Min, Young Joo;
    • Choi, Yoon Hee;
    • Ryu, Jeong-Seon;
    • Park, Sun Hyo;
    • Ahn, Hee Kyung;
    • Shim, Byoung-Yong;
    • Lee, Ki Hyeong;
    • Lee, Sung Yong;
    • Kim, Jin-Soo
    Publication type:
    Article
    27
    28
    29
    30
    31
    32

    Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03197-9
    By:
    • Kim, Sang-A;
    • Park, Hyejoo;
    • Kim, Kui-Jin;
    • Kim, Ji-Won;
    • Sung, Ji Hea;
    • Nam, Milang;
    • Lee, Ju Hyun;
    • Jung, Eun Hee;
    • Suh, Koung Jin;
    • Lee, Ji Yun;
    • Kim, Se Hyun;
    • Lee, Jeong-Ok;
    • Kim, Jin Won;
    • Kim, Yu Jung;
    • Kim, Jee Hyun;
    • Bang, Soo-Mee;
    • Lee, Jong Seok;
    • Lee, Keun-Wook
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50